Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
Saved in:
| Title: | Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Schumacher HR Jr; University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA. schumacr@mail.med.upenn.edu, Sundy JS, Terkeltaub R, Knapp HR, Mellis SJ, Stahl N, Yancopoulos GD, Soo Y, King-Davis S, Weinstein SP, Radin AR |
| Corporate Authors: | 0619 Study Group |
| Source: | Arthritis and rheumatism [Arthritis Rheum] 2012 Mar; Vol. 64 (3), pp. 876-84. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium: Internet ISSN: 1529-0131 (Electronic) Linking ISSN: 00043591 NLM ISO Abbreviation: Arthritis Rheum Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
